Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 4/Signature 2

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/11/09

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 4: Figure S4

Description: Differentially abundant bacterial taxa between the naive and TB + HRZ groups at 3months into anti-tuberculosis HR(H-Isoniazid, R-Rifampin) therapy.

Abundance in Group 1: decreased abundance in TB +HRZ group - 3months HR(W16)

NCBI	Quality Control	Links
Tyzzerella
Alkaliphilus
Acetivibrio
Stomatobaculum
Anaerovorax
Syntrophococcus
Butyricicoccus
Hespellia
Acidaminobacter
Sporobacter
Acetanaerobacterium
Pseudobutyrivibrio
Erysipelotrichaceae
Dysgonomonas
Coprobacter
Bacteroides

Revision editor(s): KateRasheed